IRIS UniCatt

Graziani, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.287
AS - Asia 3.762
EU - Europa 3.118
SA - Sud America 743
AF - Africa 115
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.043
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.143
SG - Singapore 1.663
CN - Cina 914
DE - Germania 800
IT - Italia 676
BR - Brasile 619
SE - Svezia 461
VN - Vietnam 338
FR - Francia 319
GB - Regno Unito 180
IE - Irlanda 155
IN - India 133
JP - Giappone 119
ID - Indonesia 103
HK - Hong Kong 99
FI - Finlandia 91
BD - Bangladesh 89
UA - Ucraina 83
RU - Federazione Russa 78
CA - Canada 75
NL - Olanda 55
KR - Corea 52
AR - Argentina 46
PL - Polonia 44
IQ - Iraq 41
MX - Messico 41
TR - Turchia 40
ZA - Sudafrica 40
AT - Austria 36
ES - Italia 24
IR - Iran 20
EC - Ecuador 19
PK - Pakistan 19
SA - Arabia Saudita 18
BE - Belgio 17
VE - Venezuela 17
CI - Costa d'Avorio 16
JO - Giordania 16
UZ - Uzbekistan 14
LT - Lituania 13
CO - Colombia 12
IL - Israele 12
MA - Marocco 12
CL - Cile 11
EG - Egitto 10
AU - Australia 9
CH - Svizzera 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
RO - Romania 8
DZ - Algeria 7
NP - Nepal 7
PE - Perù 7
PH - Filippine 7
TN - Tunisia 7
BG - Bulgaria 6
GR - Grecia 6
KZ - Kazakistan 6
PY - Paraguay 6
RS - Serbia 6
CU - Cuba 5
CZ - Repubblica Ceca 5
HR - Croazia 5
HU - Ungheria 5
JM - Giamaica 5
MD - Moldavia 5
PS - Palestinian Territory 5
PT - Portogallo 5
AL - Albania 4
AZ - Azerbaigian 4
KH - Cambogia 4
LB - Libano 4
LV - Lettonia 4
MK - Macedonia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
UY - Uruguay 4
AO - Angola 3
BY - Bielorussia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
MY - Malesia 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
EU - Europa 2
KW - Kuwait 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 12.024
Salva come PNG Salva come JPEG
Città #
Singapore 943
Ashburn 513
San Jose 506
Chandler 472
Beijing 196
New York 167
Rome 160
Hefei 151
Dublin 145
Ho Chi Minh City 119
Los Angeles 112
Tokyo 108
Lauterbourg 106
St Louis 106
The Dalles 104
Jakarta 90
Hanoi 89
Milan 89
Hong Kong 88
Frankfurt am Main 78
Marseille 64
San Mateo 63
São Paulo 61
Munich 59
Nanjing 56
Boston 55
Jacksonville 55
Moscow 50
Seoul 49
Ann Arbor 45
Wilmington 43
Dallas 42
Helsinki 42
Kent 42
Buffalo 39
London 38
Houston 36
Nürnberg 36
Nuremberg 34
Santa Clara 34
Princeton 30
Bremen 29
Stockholm 29
Seattle 28
Warsaw 28
Chicago 27
Council Bluffs 25
Boardman 23
Cattolica 23
Orem 23
Tukwila 23
Chennai 22
Paris 22
Johannesburg 21
Lappeenranta 21
Montreal 21
Rio de Janeiro 21
Toronto 21
Amsterdam 20
Brooklyn 19
Mexico City 19
Atlanta 18
Bologna 18
Dearborn 18
Nanchang 18
North Bergen 18
Vienna 18
Washington 18
Baghdad 17
Brussels 17
Denver 17
Düsseldorf 17
Haiphong 17
Pune 17
Redwood City 17
Roubaix 17
Tianjin 17
Abidjan 16
Amman 16
Phoenix 15
Poplar 15
Woodbridge 15
Da Nang 13
Lawrence 13
Mumbai 13
Palermo 13
San Francisco 13
Tashkent 13
Turku 13
Belo Horizonte 12
Enterprise 12
Las Vegas 12
Manchester 12
Salvador 12
Bexley 11
Guangzhou 11
Guarulhos 11
Brasília 10
Curitiba 10
Fairfield 10
Totale 6.350
Salva come PNG Salva come JPEG
Nome #
Paradoxical preservation of vascular function in severe obesity 358
Right ventricular-pulmonary artery coupling assessed by two-dimensional strain predicts in-hospital complications in Takotsubo syndrome 237
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery 218
Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications 215
Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects 202
Endothelial progenitor cells in morbid obesity 201
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery 195
Thromboxane production in morbidly obese subjects 191
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy 180
Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives 169
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 166
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 165
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 165
Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances 161
Prevalence and Clinical Correlates of Cerebrovascular Alterations in Fabry Disease: A Cross-Sectional Study 160
Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions 160
Right Ventricular Hypertrophy, Systolic Function, and Disease Severity in Anderson-Fabry Disease: An Echocardiographic Study 157
Coronary Microvascular Dysfunction Is Associated With a Worse Cardiac Phenotype in Patients With Fabry Disease 150
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 149
Heart Team e malattie valvolari: L’importanza di un approccio multidisciplinare 148
Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience 146
Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery" 144
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial 142
A multimodal approach to predict prosthesis-patient mismatch in patients undergoing valve-in-valve trans-catheter aortic valve implantation 137
Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial 131
Early Right Heart Chambers Reverse Remodeling in Patients Operated in Adulthood for Congenital Lesions Associated with Right Heart Chambers Enlargement 131
Acute haemodynamic impact of transcatheter aortic valve implantation in patients with severe aortic stenosis 129
Right ventricle systolic function and right ventricle-pulmonary artery coupling in patients with severe aortic stenosis and the early impact of TAVI 128
Right ventricular strain in Anderson-Fabry disease 125
An uplifted destiny for mucopolysaccharidosis type I with heart involvement 123
Global longitudinal strain for prediction of mortality in ST-segment elevation myocardial infarction and aortic stenosis patients: two sides of the same coin 121
Performance, clinical outcomes and implementation of an original heart valve clinic model 121
Inflammation across the spectrum of hypertrophic cardiac phenotypes 118
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 118
Early cardiac mechanics abnormalities in patients with mitochondrial diseases 117
When compassionate is appropriate for end-stage aortic valve stenosis? 117
Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease 117
Diagnostic role of echocardiography in patients admitted to the emergency room with suspect no-ST-segment elevation acute myocardial infarction 116
Diagnosis and management of peripartum cardiomyopathy and recurrence risk 115
Pulmonary congestion assessed by lung ultrasound in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: Prevalence and prognostic implications 114
Echocardiographic left atrial stiffness index predicts high left ventricular filling pressures in patients with acute heart failure: an observational study 113
Valvular heart disease and cardiomyopathy: reappraisal of their interplay 113
Massive Coronary Microvascular Dysfunction in Severe Anderson-Fabry Disease Cardiomyopathy 113
Unexpected Left Ventricle Pseudoaneurysm With Unusual Origin: History of a Diseased Annulus Broken Into a Diseased Myocardium 112
Association of Cardiac Sarcoidosis and Ulcerative Colitis: A Case Report and a Brief Review of the Literature 110
Transcatheter aortic valve implantation in pure aortic regurgitation: Hemodynamic and echocardiographic findings in bioprosthesis vs. native valve 110
Right ventricular strain in Fabry disease: Prognostic implications 108
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 108
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 107
Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study 105
Pulmonary artery sling in a 22-month-old boy with 18q deletion syndrome: A rare but possible association 105
Pregnancy outcome and left ventricular ejection fraction in women with history of myocardial infarction 105
Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy 105
Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function 103
Right ventricle-pulmonary artery coupling in repaired tetralogy of Fallot with pulmonary regurgitation: Clinical implications 101
Telemedicine for adult congenital heart disease patients during the first wave of COVID-19 era: a single center experience 101
Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy 100
Right atrial strain in Anderson-Fabry disease 100
Emerging multisystem biomarkers in hereditary transthyretin amyloidosis: a pilot study 100
Transthoracic Echocardiography in Assessing Patients with Suspected Infective Endocarditis (TEASE): An Exploratory Study 100
Evolution of Cardiac Damage Staged With Echocardiography in Fabry Disease 100
Pregnancy outcome and left ventricular ejection fraction in women with history of myocardial infarction 100
Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: The role of thrombosis, fibrinolysis and atherosclerotic burden. 98
Successful Transcatheter Treatment of Left Pulmonary Artery to Left Atrium Communication Diagnosed in Adulthood 98
Telemedicine for adult congenital heart disease patients during the first wave of COVID-19 era: a single center experience 98
Left atrial strain analysis improves left ventricular filling pressures non-invasive estimation in the acute phase of Takotsubo syndrome 97
Atypical Thrombosis Following Mitral Transcatheter Edge-to-Edge Repair: Face to Face Between Scar and Clip 96
Temporal trends of frame expansion and paravalvular leak reduction after transcatheter aortic valve replacement with self-expandable prostheses 95
Evolution and Prognostic Impact of Right Ventricular-Pulmonary Artery Coupling After Transcatheter Aortic Valve Replacement 94
Early Hemodynamic and Structural Impact of Transcatheter Aortic Valve Replacement in Pure Aortic Regurgitation 94
Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis 93
Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function 93
Impact of severe valvular heart disease in adult congenital heart disease patients 93
A Novel Hemodynamic Index Characterizing Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair: The MPF 93
Evaluation of Adults With Congenital Heart Disease 91
Cardiac Magnetic Resonance Features of Fabry Disease: From Early Diagnosis to Prognostic Stratification 88
Management, Flow, and Outcomes of Patients with Aortic Stenosis Followed by a Heart Valve Clinic: The Untold "Behind the Scene" from a High-Volume, Real-World Experience 88
Comparison of De-Kay repair versus De Vega suture for functional tricuspid regurgitation: a preliminary experience 87
The Heart in Fabry Disease: Mechanisms Beyond Storage and Forthcoming Therapies 83
Undiagnosed Severe Late Complications of Repaired Tetralogy of Fallot 83
An uplifted destiny for mucopolysaccharidosis type I with heart valve involvement 81
Early improvement of strain imaging parameters predicts long-term response to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: An observational prospective study 80
Anderson-Fabry's Disease: A Rare but Treatable Case of Fever of Unknown Origin 79
Treating heart failure with preserved ejection fraction: learning from pulmonary fibrosis 79
ECG-based score estimates the probability to detect Fabry Disease cardiac involvement 77
Non-invasive imaging of ventricular-atrial fistulization secondary to infective rupture of caseous calcification of the mitral annulus 77
Severe silent myocardial ischemia during echocardiographic examination in a patient during cardiac screening for a kidney transplant intervention 76
Pregnancy in hypertrophic cardiomyopathy: New data, old questions 75
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease 75
Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction 75
An unusual case of mitral valve chordal rupture 73
Right ventricular to pulmonary artery coupling and prognosis in transthyretin cardiac amyloidosis 72
Généreux staging classification in predicting left ventricular reverse remodeling after intervention for severe aortic valve regurgitation 71
Modified Warden procedure in adult with partial anomalous pulmonary venous connection after previous atrial septal defect repair 71
Dynamic modulation of coronary arterio-venous communications 70
Subclinical dysfunction of remote myocardium is related to high NT-proBNP and affects global contractility at follow-up, independently of infarct area 70
Prognostic Implications of the Extent of Cardiac Damage in Patients With Fabry Disease 69
Echocardiography in Anderson-Fabry Disease 67
Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders 64
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease 63
Totale 11.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.554
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022500 11 22 4 32 47 13 8 97 22 44 101 99
2022/20231.445 160 152 119 203 66 167 95 138 144 112 67 22
2023/2024977 40 240 49 59 51 178 42 35 34 42 90 117
2024/20252.208 35 59 150 74 160 67 82 92 324 195 585 385
2025/20265.794 818 233 346 671 804 330 961 291 376 501 322 141
Totale 12.201